Alpha-Klotho 5mg — Vial Spec, Reconstitution Math & COA
A 5mg vial of lyophilized Alpha-Klotho provides high-yield material for high-throughput in vitro assays and extensive preclinical experimental models. Designed strictly for laboratory research use only, this format allows investigators to prepare precise stock concentrations while maintaining lot-to-lot consistency. This technical guide outlines reconstitution calculations, aliquot strategies, stability profiles, and analytical validation standards.
Quick answer
A 5mg vial of lyophilized Alpha-Klotho provides high-yield material for high-throughput in vitro assays and extensive preclinical experimental models. Designed strictly for laboratory research use only, this format allows investigators to prepare precise stock concentrations while maintaining lot-to-lot consistency. This technical guide outlines reconstitution calculations, aliquot strategies, stability profiles, and analytical validation standards.
Key takeaways
- The 5mg specification of Alpha-Klotho represents a standardized, high-yield quantity tailored for complex laboratory workflows, including cell culture administration, receptor binding kinetics, and enzymatic activity profiling.
- Accurate concentration calculations are vital to maintain experimental reproducibility and prevent pipetting errors during serial dilutions.
- Reconstituting peptide compounds in single-use or limited-use stock solutions is critical for preserving secondary and tertiary peptide structure.
- Every batch of research-grade Alpha-Klotho supplied by PX1 Research undergoes rigorous third-party analytical verification prior to laboratory release.
Overview and Mass Specification of the Alpha-Klotho 5mg Vial
The 5mg specification of Alpha-Klotho represents a standardized, high-yield quantity tailored for complex laboratory workflows, including cell culture administration, receptor binding kinetics, and enzymatic activity profiling. Alpha-Klotho is a transmembrane protein—and soluble circulating factor—extensively studied in the contexts of mineral homeostasis, fibroblast growth factor 23 (FGF23) signaling, cellular senescence, and skeletal muscle regeneration models. In a lyophilized state, a 5mg vial contains 5,000 micrograms of active peptide mass, stabilized with minimal bulking agents to ensure consistent solubility and minimal osmotic disturbance upon reconstitution.
Principal investigators and laboratory managers frequently select the 5mg vial configuration when running multi-plate in vitro studies or serial administration protocols in rodent models. Purchasing single 5mg unit formats minimizes batch variation across experimental replicates compared to using multiple micro-gram quantity vials. Investigators looking to source verified material can review PX1 Research's full catalog via the all peptides portal or evaluate related specialized listings such as Alpha-Klotho recombinant constructs.
Reconstitution Mathematics for 5mg Vials: Concentration Protocols
Accurate concentration calculations are vital to maintain experimental reproducibility and prevent pipetting errors during serial dilutions. Reconstitution of a 5mg (5,000 µg) vial of Alpha-Klotho depends on the desired working concentration and volume constraints of the laboratory assay. Common diluents include sterile bacteriostatic water, sterile 0.9% sodium chloride, or laboratory-grade phosphate-buffered saline (PBS, pH 7.4) depending on assay sensitivity to preservative agents.
When adding 1.0 mL of sterile diluent to a 5mg vial, the resulting stock concentration is exactly 5.0 mg/mL (5.0 µg/µL or 5,000 µg/mL). If 2.0 mL of solvent is introduced, the solution yields a concentration of 2.5 mg/mL (2.5 µg/µL or 2,500 µg/mL). Introducing 3.0 mL of solvent yields a working stock concentration of approximately 1.67 mg/mL (1.67 µg/µL or 1,666.7 µg/mL). For automated dilution assistance, scientists should utilize the PX1 reconstitution calculator to determine precise volumetric requirements for custom target concentrations.
Aliquot Planning, Diluent Selection, and Freeze-Thaw Mitigation
Reconstituting peptide compounds in single-use or limited-use stock solutions is critical for preserving secondary and tertiary peptide structure. Subjecting reconstituted Alpha-Klotho solutions to multiple freeze-thaw cycles leads to molecular aggregation, precipitation, and significant loss of biological activity. Upon full dissolution of the lyophilized cake, the primary stock solution should immediately be divided into working aliquots within sterile, low-binding polypropylene microcentrifuge tubes.
Diluent selection must be aligned with downstream experimental applications. For long-term frozen storage (typically at -20°C or -80°C), adding a carrier protein such as 0.1% Bovine Serum Albumin (BSA) or Human Serum Albumin (HSA) to phosphate-buffered saline helps prevent non-specific adsorption of Alpha-Klotho to the plastic container walls. If the reconstituted compound is to be used in microplate assays over a 24 to 48-hour period, storage at 2°C to 8°C in sterile, non-preserved PBS is recommended to prevent cellular toxicity associated with benzyl alcohol preservatives.
Certificate of Analysis (COA), Analytical Purity, and Endotoxin Standards
Every batch of research-grade Alpha-Klotho supplied by PX1 Research undergoes rigorous third-party analytical verification prior to laboratory release. High-Performance Liquid Chromatography (HPLC) is conducted to verify sequence purity, requiring a threshold of ≥98.0%. Mass Spectrometry (MS) is simultaneously performed to confirm exact molecular weight match against theoretical values, ensuring the absolute absence of truncated fragments or side-reaction impurities.
Because Alpha-Klotho is frequently introduced to sensitive cell culture media and in vivo rodent models, endotoxin content is strictly limited. Bacterial endotoxins (lipopolysaccharides) can provoke non-specific inflammatory signaling via Toll-like receptor pathways, yielding false-positive responses in cell proliferation or signaling assays. PX1 Research enforces an endotoxin standard of <0.1 EU/µg, verified via Limulus Amebocyte Lysate (LAL) testing. Laboratory personnel can verify individual lot results at any time via our dedicated COA lookup portal.
Thermal Stability, Handling Guidelines, and Storage Protocols
Proper physical handling and temperature control are required to maintain structural integrity from receipt through assay execution. Unopened, lyophilized 5mg vials of Alpha-Klotho exhibit superior thermal stability and may be stored at -20°C for up to 24 months. For extended archival storage, maintaining ambient temperatures at -80°C in a desiccated environment is optimal.
During transport, lyophilized vials remain stable at room temperature for brief periods (3 to 7 days), though rapid transition to cold storage upon arrival at the receiving dock is standard operating procedure. When preparing for reconstitution, allow the vial to reach room temperature before introducing solvent to minimize thermal shock and condensation. Vigorous vortexing or violent shaking must be strictly avoided; gentle inversion or gentle swirling of the vial is required to fully dissolve the cake without inducing shear-stress aggregation.
Comparative Analysis: Selecting the 5mg Spec vs. Alternate Formats
Selecting the correct vial size depends directly on experimental scale and throughput requirements. A 5mg vial format is ideal for core facilities and high-volume laboratories conducting systematic dose-response curves or long-term preclinical rodent studies requiring substantial material mass over consecutive days.
For smaller exploratory assays or initial feasibility trials, micro-gram scale vials (such as 100µg or 1mg variants) may prevent material waste. Conversely, large academic institutes and industrial biotech entities requiring multi-gram quantities or custom packaging should consult our wholesale lab account department to configure bulk manufacturing lots, standardized custom fills, and scheduled delivery pipelines.
Preclinical Receptor Dynamics and Molecular Targets of Alpha-Klotho
In preclinical model systems, Alpha-Klotho functions primarily as an essential co-receptor for Fibroblast Growth Factor 23 (FGF23), forming a high-affinity complex with FGF receptors (FGFR1c, FGFR3c, FGFR4). This binding complex regulates phosphate excretion, vitamin D biosynthesis, and mineral homeostasis in renal tubular epithelium models. Beyond its membrane-bound signaling functions, the shed soluble form of Alpha-Klotho acts as an endocrine factor that modulates multiple cell-signaling cascades.
In vitro data indicate that soluble Alpha-Klotho modulates Wnt/β-catenin signaling, suppresses insulin/IGF-1 pathway hyperactivation, and mitigates oxidative stress via upregulation of manganese superoxide dismutase (MnSOD). Furthermore, preclinical muscle damage models demonstrate that recombinant Klotho administration supports progenitor cell proliferation and lineage commitment, positioning it as a key focus in regenerative muscle research and senescence investigation.
Class Comparison: Alpha-Klotho and Related Preclinical Strength Peptides
Alpha-Klotho belongs to a broader class of research compounds investigated for their roles in tissue adaptation, satellite cell modulation, and metabolic regulation. While Alpha-Klotho acts primarily through FGF23 co-receptor activation and enzyme-like signaling regulation, other research peptides target distinct molecular pathways within muscle hypertrophy and strength models. Understanding these mechanistic differences allows researchers to design complementary target-validation protocols.
For instance, researchers examining muscle mass regulation pathways frequently evaluate Follistatin-315, a native binding protein that neutralizes myostatin and activin A to drive hyperplastic pathways. Similarly, studies investigating endocrine growth pathways often utilize IGF-1 LR3, an analog engineered with reduced binding affinity for IGF-binding proteins (IGFBPs), leading to extended biological half-life in vitro. Broad-spectrum metabolic and tissue repair mechanisms are also explored in our primary research library.
PX1 Research Quality Control and Supply Chain Integrity
PX1 Research operates dedicated, USA-based synthesis and packaging facilities complying strictly with cGMP guidelines and ISO 17025 laboratory quality standards. Every 5mg vial of Alpha-Klotho is filled in cleanroom environments, nitrogen-flushed, and sealed with tamper-evident flip-off caps to guarantee structural stability and sterility.
Orders are processed with same-day dispatch (Monday through Friday) operating out of our dual fulfillment hubs located in California and Arizona. By managing localized domestic inventory, PX1 Research eliminates international customs delays and cold-chain breakdowns, ensuring research institutions receive high-purity research compounds with total analytical transparency.
Frequently Asked Questions
What is the physical state and target concentration of an Alpha-Klotho 5mg vial?
The vial contains 5mg (5,000 µg) of sterile, lyophilized white cake or powder. Depending on the volumetric reconstitution with sterile diluent (e.g., 1mL to 3mL), target stock concentrations range from 5.0 mg/mL to 1.67 mg/mL for in vitro and laboratory protocols.
How is the purity and mass of the Alpha-Klotho 5mg vial verified?
Each lot is tested using High-Performance Liquid Chromatography (HPLC) to confirm sequence purity ≥98% and Mass Spectrometry (MS) to verify exact molecular weight. Lot-specific analytical reports are published on our COA lookup page.
What diluent is recommended for reconstituting Alpha-Klotho for cell culture assays?
For cell culture applications, sterile non-preserved Phosphate-Buffered Saline (PBS, pH 7.4) or sterile water is recommended. If long-term frozen storage of aliquots is required, adding 0.1% carrier protein (such as BSA) helps prevent adsorption to vial walls.
What are the endotoxin limits for PX1 Research Alpha-Klotho vials?
PX1 Research enforces a strict endotoxin threshold of <0.1 EU/µg as determined by LAL (Limulus Amebocyte Lysate) assay testing, preventing non-specific inflammatory responses in cellular assays.
Can reconstituted Alpha-Klotho 5mg stock solutions undergo multiple freeze-thaw cycles?
No. Freeze-thaw cycles cause physical denaturation and protein aggregation. Reconstituted stock solutions must be aliquoted into single-use volumes and stored at -20°C or -80°C.
Is Alpha-Klotho 5mg suitable for human administration or clinical trials?
No. Alpha-Klotho 5mg is supplied strictly as a research chemical for in vitro, laboratory, and preclinical animal research models. It is not for human or veterinary medical, therapeutic, or diagnostic use.
How does Alpha-Klotho interact with FGF23 receptors in preclinical models?
In vitro and animal models demonstrate that Alpha-Klotho binds directly to Fibroblast Growth Factor Receptors (FGFR1c, FGFR3c, FGFR4) to form a high-affinity co-receptor complex necessary for downstream FGF23 signal transduction.
Where does PX1 Research ship Alpha-Klotho 5mg vials from?
All orders are fulfilled directly from our USA-based facilities in California and Arizona, featuring same-day shipping for orders placed Monday through Friday.
Related pages
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.